On Trip To Turkey, UK Woman Dies Of 'Cardiac Arrest', Autopsy Reveals Her Heart Is Missing
Last Updated:
Beth Martin from England's Portsmouth died unexpectedly in Turkey. Her husband, who claims her heart was missing, is seeking answers from concerned Turkish authorities.
A trip to Turkey turned into a nightmare after a 28-year-old woman from England passed away unexpectedly. What makes it more tragic is the claim of the woman's husband who alleges that her wife's heart was missing from her chest cavity.
The deceased has been identified as Beth Martin of England's Portsmouth. She is said to have succumbed to an unexplained illness. The bereaved family is seeking answers after a post-mortem report revealed her heart was missing.
According to media reports, Martin initially blamed food poisoning for her ill health. She became 'delirious" and was admitted to Marmara University Pendik Education and Research Hospital in Istanbul within hours of arriving in the city.
The New York Post reported that the UK woman breathed her last the following day, on April 28.
Meanwhile, the Turkish Health Ministry claimed Martin died of 'cardiac arrest due to multiple organ failure" but did not mention the detailed cause of demise.
Beth's husband, Luke Martin, alleged Turkish officials were uncooperative and initially assumed she was poisoned by him.
After successfully arranging to repatriate her to the UK, British coroners informed him that his wife's heart was missing.
The devastated family reported possible medical incompetence, a poorly conducted probe, and horrible mismanagement by Turkish authorities.
However, the Turkish authorities claimed the deceased 'did not undergo any surgical procedures" during the initial autopsy at the hospital where she passed away, disputing the British coroners' inferences.
Her family doubts whether the medical staff at the Istanbul hospital gave her penicillin before realising she had a medication allergy.
Further, her death is currently being probed.
The couple along with their two young children, Elouise, 8, and Tommy, 5, left for a dream vacation to Turkey on April 27, only to experience a nightmare after Beth fell ill during the flight.
Later, a GoFundMe page was created in the name of Beth with an aim of raising 250K pounds (approximately Rs 28 lakh).
The NY Times report mentioned that the grieving family alleged the Turkish doctors hid the truth from them and that she was 'pinned down, poked and prodded invasively" before her death. They are still in shock wondering what might have transpired in her last hours.
It would take nearly six months for British coroners to ascertain the cause behind Beth's sudden multiple organ to failure.
Watch India Pakistan Breaking News on CNN-News18. Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated!
First Published:
May 26, 2025, 13:41 IST
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
2 hours ago
- NDTV
US Girl, 19, Dies After Trying Viral "Dusting" Challenge. All About This Deadly Social Media Trend
A 19-year-old girl in the US died on Sunday after taking part in a deadly social media trend called "dusting". According to The Independent, Renna O'Rourke from Arizona died after spending four days in the intensive care unit (ICU). Her parents said that she and her boyfriend ordered aerosol keyboard cleaner without their knowledge. After inhaling the keyboard cleaner, the teen went into cardiac arrest, spent a week unconscious in the ICU and then was declared brain dead. "She always said, 'I'm going to be famous, dad. Just you watch. I'm going to be famous,' and unfortunately, this is not under the most optimal of circumstances," the girls' father Aaron O'Rourke, said, per the outlet. "Dusting," also known as "chroming" or "huffing," is a viral trend that involves inhaling common household cleaners to get high for views online. The sensation reportedly causes brief euphoria but can cause instant, fatal damage, often due to heart failure, according to the Cleveland Clinic. According to a GoFundMe page, Renna was pronounced brain dead after purposely breathing in the cleaning spray. "There's no ID required. It's odourless. It's everything kids look for. They can afford it, they can get it, and it doesn't show in mom and dad's drug test," Renna's mother, Dana O'Rourke, said, per People. "She never regained consciousness," her mother added. Renna's parents described their late daughter as "vivacious and caring and loyal." Her father said that the 19-year-old loved to sing and lit up every room with her smile and laughter. Now, the O'Rourke family is working to honour Renna by spreading the word about the dangers of huffing for teens and parents. "Dig deep. Search their rooms. Don't trust - and that sounds horrible, but it could save their life," the mother said. They also started a GoFundMe page to cover the extensive medical bills, burial costs and therapy costs. Renna's father also plans to use the proceeds to spread awareness about the dangers of Huffing/Dusting, the practice of inhaling keyboard cleaner or similar. Notably, this trend has been around for years. In March 2024, an 11-year-old boy from the U.K. died after copying videos he had seen on social media of people sniffing or inhaling toxic substances. Figures cited by CNN also show an increase in the number of teens taking part in this deadly trend. From 2015 to 2022, the number of 12- to 17-year-old American adolescents using inhalants declined from 684,000 in 2015 to 554,000 in 2022, according to the US Substance Abuse and Mental Health Services Administration.
India Today
4 hours ago
- India Today
How animal bite deaths hit MP villagers even after rabies vaccination
A spate of deaths has hit a group of mostly tribal people who had assembled for a wedding at Limbai village in Madhya Pradesh's Barwani district, spreading panic. Six people have died since early May—the last one on June 2—after being bitten by an animal suspected to be a rabid morning on May 5, an animal bit 17 people sleeping outside their homes in Limbai, located some 45 km from Barwani town. The victims, some of whom had come from other villages for a wedding, described the animal as resembling a search was launched but the animal was never traced, until on June 4 when forest department staff found the remains of an animal, with its legs tied, in a dry well near the village.'We suspect the remains are that of a jackal. The animal was perhaps caught, killed and thrown into the well. We have sent the remains for a lab test,' said Ashish Bansod, divisional forest officer, Barwani. Three people died on May 23, one each on May 27 and June 1 and another person on June 2. All of them had been administered anti-rabies vaccines immediately after being bit. Three heads of cattle also died after being bitten by the families of the deceased have been paid Rs 8 lakh each as compensation, informed could have caused the deaths even after vaccines were administered? The district administration has sent samples of the vaccines for tests. Samples and swabs drawn from the deceased have also been sent for tests to ascertain if the fatalities were indeed caused by rabies.'If not stored properly or if the cold chain is broken, the efficacy of drugs may reduce. At times, if the schedule of injections is not followed, efficacy goes down as well,' said Dr Avinash Dube, a medical remaining 11 people who suffered bites are under observation at medical facilities, including the MY Hospital at divisional headquarters Indore. 'There is panic among the affected since the deaths happened even after taking the vaccine shots,' said a family to India Today Magazine
News18
4 hours ago
- News18
81,000 Vials, Rs 24 Crore In 3 Months: Weight Loss Drug Mounjaro Sales Triple As Patients Shift To Higher Dose
With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March In a sign of rising adoption, sales of Mounjaro—the breakthrough weight loss and type 2 diabetes drug—have nearly tripled in the last two months, data shows. American drugmaker Eli Lilly launched Mounjaro in India on March 20, triggering immediate frenzy, especially among those looking to achieve weight loss and glucose control. Doctors told News18 they were flooded with requests from patients eager to start Mounjaro or learn more about its benefits. With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March. The higher dosage form of five milligram, in particular, more than doubled in value and quantity sales between April and May, indicating a strong trend of patient progression to the next stage of treatment. As per the medical protocol, patients start with lower dosage of 2.5 milligram weekly dose and upgrade to 5 milligram after four weeks. 'This clinical shift is clearly reflected in market numbers. Five mg pack sales jumped from Rs 3.08 crore in April to Rs 7.53 crore in May, while unit sales rose from over 9,300 to over 22,900," Sheetal Sapale, vice-president (commercial), Pharmatrac, told News18. 'Looking at these trends and the acceptance of this therapy—by physicians as well as patients—along with the affordable pricing of Rs 18,000 to Rs 22,000 per month dosage indicates a definite pick up in consumption." The total market for Mounjaro has reached Rs 23.94 crore over the past three months, selling more than 81,000 vials of the drug—signalling growing adoption in diabetes care protocols. According to Dr Anoop Misra, chairman, Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, clinical use of Mounjaro in India closely reflects the trends observed in the data. 'A substantial number of patients are being initiated at 2.5 mg, with a timely escalation to 5 mg in line with recommended protocols. This pattern suggests good tolerability and early clinical efficacy in glycemic control and weight reduction." Misra told News18: 'With growing familiarity and broader access, increased use of higher doses (7.5 mg and above) is likely, especially in patients requiring enhanced metabolic outcomes." The injectable drug is approved by India's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO). Mounjaro is a once-weekly injection priced at Rs 4,375 for a 5 mg vial and Rs 3,500 for a 2.5 mg vial, making the monthly expenditure around Rs 14,000-Rs 17,500. The drug is claimed to be 80 per cent cheaper than in the United States. Entry-Level Dosage Sales Plateau Mounjaro, the brand name for Tirzepatide, a once-weekly injectable, is a first-in-class medication that combines the effects of two naturally occurring hormones: GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1). Data shows that the 2.5mg dose of Mounjaro—generally prescribed as the starting regimen for type 2 diabetes patients or those looking to shed weight—has shown signs of 'plateauing growth". This trend confirms a gradual shift to higher doses. The sales value for the 2.5 mg injection rose marginally from Rs 4.80 crore in April to Rs 5.08 crore in May, after a steeper increase from Rs 1.42 crore in March. The data shows that the unit sales also reflect this trend, increasing from 5,400 in March to 18,270 in April, but only marginally to 19,350 in May. While the 2.5 mg variant remains essential for entry-level patient initiation, its month-on-month growth may continue to taper off as the patient base matures and advances to the next phase of dosing.
